EIMI: iShares Core MSCI Emerging Markets IMI UCITS ETF (Acc) returns, drawdowns and risk
Funds on emerging and Asian markets, as a block or country by country. Also listed as IS3N on Xetra and EMIM in London.
Data updated October 2026
EIMI · Borsa Italiana · EURCategory: Emerging markets and Asia ETFsData from July 2014
From July 2014 to October 2026 EIMI returned 7.3% a year on average with dividends reinvested, in euros: €10,000 invested at the start grew to €23,711.
Its deepest fall was 35.0%, from April 2015 to February 2016, and it took about 30 months to get back to the previous high. Annual volatility was 19.7%; at the last close it was 8.6% below its high.
Against VWCE (Vanguard FTSE All-World UCITS ETF (Acc)), over the 87 months both have data, the correlation of monthly returns was 0.73: they usually moved together. Beta was 0.85. In months when VWCE rose, EIMI moved 86% as much on average; in months when VWCE fell, 97% as much.
Key figures
- Annual return (CAGR)
- +7.3%
- 1-year return
- +21.2%
- 5 years, a year
- +7.7%
- 10 years, a year
- +8.1%
- Annual volatility
- 19.7%
- Maximum drawdown
- −35.0%
- Sharpe ratio
- 0.44
- Worst year
- 2022: −15.1%
Trailing returns
| Period | EIMI | VWCE |
|---|---|---|
| 1 year | +21.2% | +22.0% |
| 3 years, a year | +19.9% | +19.5% |
| 5 years, a year | +7.7% | +11.5% |
| 10 years, a year | +8.1% | — |
To the last close of October 2026. Periods longer than a year are annualised.
Growth of €10,000: EIMI vs VWCE
Month-end values from August 2019, the first month both funds have data.
EIMI drawdowns
Percentage below the previous high, weekly.
Returns by calendar year
| Year | EIMI | VWCE |
|---|---|---|
| 2026(partial) | +20.8% | +17.5% |
| 2025 | +17.2% | +9.2% |
| 2024 | +14.1% | +24.4% |
| 2023 | +7.8% | +18.2% |
| 2022 | −15.2% | −13.5% |
| 2021 | +7.8% | +28.6% |
| 2020 | +7.8% | +5.4% |
| 2019 | +20.2% | +7.6% |
| 2018 | −10.6% | — |
| 2017 | +20.9% | — |
| 2016 | +13.3% | — |
| 2015 | −4.7% | — |
| 2014(partial) | −1.5% | — |
EIMI compared
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
Sharpe ratio uses the return of short-term government bills in the same currency as the risk-free rate. The growth chart uses month-end values; drawdowns and volatility use daily closes.
Questions
What is the average annual return of EIMI?
From July 2014 to October 2026 EIMI returned 7.3% a year on average (CAGR) with dividends reinvested, in EUR. Over the last 5 years: +7.7% a year. Over the last 12 months: +21.2%.
What was the worst drawdown of EIMI?
35.0%, from April 2015 to February 2016; it took about 30 months from the previous high to get back to it.
How volatile is EIMI?
Annual volatility was 19.7% over the period. Its worst month was −14.4% and 56% of months were positive. Worst calendar year: 2022 (−15.1%).
How closely does EIMI follow VWCE?
Over 87 months the correlation of monthly returns was 0.73, so they usually moved together, with a beta of 0.85.
Use EIMI in a free tool
Other Emerging markets and Asia ETFs
- All Emerging markets and Asia ETFsReturns and risk side by side
- VWO — Vanguard FTSE Emerging Markets ETFCAGR +9.6%
- IEMG — iShares Core MSCI Emerging Markets ETFCAGR +6.0%
- EEM — iShares MSCI Emerging Markets ETFCAGR +5.2%
- VFEM — Vanguard FTSE Emerging Markets UCITS ETF (Dist)CAGR +5.1%
- XMME — Xtrackers MSCI Emerging Markets UCITS ETF 1CCAGR +6.2%
- INDA — iShares MSCI India ETFCAGR +5.0%
- MCHI — iShares MSCI China ETFCAGR +2.6%
- FXI — iShares China Large-Cap ETFCAGR +3.0%
- KWEB — KraneShares CSI China Internet ETFCAGR +1.3%
- EWT — iShares MSCI Taiwan ETFCAGR +13.4%
- EWY — iShares MSCI South Korea ETFCAGR +7.8%
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.